Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Mercedes E Gonzalez"'
Autor:
Amy S. Paller, Shireen V. Guide, Diego Ayala, Mercedes E. Gonzalez, Anne W. Lucky, Isin Sinem Bagci, M. Peter Marinkovich
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractBackground/purpose Dystrophic epidermolysis bullosa (DEB), a rare genetic skin disease caused by loss-of-function mutations in COL7A1, the gene encoding type VII collagen (COL7), is characterized by skin blistering, scarring, and extracutaneo
Externí odkaz:
https://doaj.org/article/4d22581de2c841f09a639f4a31802fdc
Autor:
Amy S. Paller, Jonathan I. Silverberg, Mercedes E. Gonzalez, Lynda C. Schneider, Robert Sidbury, Zhen Chen, Ashish Bansal, Zhixiao Wang, Randy Prescilla
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
BackgroundModerate-to-severe atopic dermatitis (AD) often has a profound impact on the quality of life of young children and their caregivers. One of the most burdensome symptoms reported by patients is skin pain.MethodsThis post hoc analysis focuses
Externí odkaz:
https://doaj.org/article/8ddb5c6e71134ef9bcfe2f99ceb78773
Autor:
Shireen V. Guide, Mercedes E. Gonzalez, I. Sinem Bağcı, Brittani Agostini, Hubert Chen, Gloria Feeney, Molly Steimer, Binoy Kapadia, Kunju Sridhar, Lori Quesada Sanchez, Franshesca Gonzalez, Matthew Van Ligten, Trevor J. Parry, Surya Chitra, Lisa A. Kammerman, Suma Krishnan, M. Peter Marinkovich
Publikováno v:
New England Journal of Medicine. 387:2211-2219
Dystrophic epidermolysis bullosa is a rare genetic blistering skin disease caused by mutations inWe conducted a phase 3, double-blind, intrapatient randomized, placebo-controlled trial involving patients 6 months of age or older with genetically conf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d053a942c03e819a50c9d47264492443
https://doi.org/10.1056/nejmoa2206663
https://doi.org/10.1056/nejmoa2206663
Autor:
Amy S Paller, Eric L Simpson, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Weily Soong, Mercedes E Gonzalez, Lynda C Schneider, Robert Sidbury, Benjamin Lockshin, Steven Meltzer, Zhixiao Wang, Leda P Mannent, Nikhil Amin, Yiping Sun, Elizabeth Laws, Bolanle Akinlade, Myles Dillon, Matthew P Kosloski, Mohamed A Kamal, Ariane Dubost-Brama, Naimish Patel, David M Weinreich, George D Yancopoulos, John T O’Malley, Ashish Bansal, Amber Pepper, David Cohen, David Pariser, Jeffrey Leflein, Jeffrey Weinberg, John Browning, Joyce Teng, Lara Wine Lee, Lawrence Sher, Lucia Diaz, Lynda Schneider, Ned Rupp, Peck Ong, Robert Cartwright, Andreas Pinter, Christina Schnopp, Anna Korkosz, Dorota Bystrzanowska, Ewa Sygula, Jacek Zdybski, Kamila Padlewska
Publikováno v:
The Lancet. 400:908-919
Current systemic treatments for children younger than 6 years with moderate-to-severe atopic dermatitis that is uncontrolled with topical therapies might have suboptimal efficacy and safety. Dupilumab is approved for older children and adults with at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d45214d2134d389bfe62af4219892e0
https://doi.org/10.1016/s0140-6736(22)01539-2
https://doi.org/10.1016/s0140-6736(22)01539-2
Autor:
Amy S Paller, Andreas Wollenberg, Elaine C Siegfried, Mercedes E Gonzalez, Benjamin Lockshin, Faisal A Khokhar, Zhen Chen, Tayler Gonzalez, Randy Prescilla
Publikováno v:
British Journal of Dermatology. 188
Many systemic therapies used for moderate-to-severe atopic dermatitis (AD) have immunosuppressive properties and necessitate laboratory screening and monitoring, adding to the treatment burden. Previous dupilumab studies in adults, adolescents and ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5b18f8c51db74f333c1c7cf7ed45a41
https://doi.org/10.1093/bjd/ljac140.032
https://doi.org/10.1093/bjd/ljac140.032
Autor:
Amy S. Paller, Elaine C. Siegfried, Michael J. Cork, Andreas Wollenberg, Peter D. Arkwright, Mercedes E. Gonzalez, Benjamin Lockshin, Zhen Chen, Ashish Bansal, Noah A. Levit, Randy Prescilla
Publikováno v:
Arkwright, P 2023, ' Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis ', Pediatric Drugs . https://doi.org/10.1007/s40272-022-00553-8
Background and ObjectivePrevious studies of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents, and severe atopic dermatitis in children aged 6 to < 12 years demonstrate no clinically important changes in la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0aafdd51fcb5f43b3726d128ab1ad54
https://research.manchester.ac.uk/en/publications/18e6b645-b1eb-4e1b-a228-cdaeca3c04b3
https://research.manchester.ac.uk/en/publications/18e6b645-b1eb-4e1b-a228-cdaeca3c04b3
Autor:
Amy S, Paller, Elaine C, Siegfried, Michael J, Cork, Andreas, Wollenberg, Peter D, Arkwright, Mercedes E, Gonzalez, Benjamin, Lockshin, Zhen, Chen, Ashish, Bansal, Noah A, Levit, Randy, Prescilla
Publikováno v:
Paediatric drugs. 25(1)
Previous studies of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents, and severe atopic dermatitis in children aged 6 to12 years demonstrate no clinically important changes in laboratory parameters. The ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e3e48cfc3c2cb4725eb53def2b99573
https://pubmed.ncbi.nlm.nih.gov/36529811
https://pubmed.ncbi.nlm.nih.gov/36529811
Autor:
Michelle Oboite, Minnelly Luu, Brandi M. Kenner-Bell, Nanette B. Silverberg, Mercedes E. Gonzalez, Sharon E. Jacob, Latanya Benjamin, JiaDe Yu, Candrice R Heath, Sarah L. Stein, Leslie Castelo-Soccio
Publikováno v:
Pediatric Dermatology. 38:90-95
Background Deficiencies in the skills necessary to diagnose and manage patients with skin of color may contribute to health disparities. The Pediatric Dermatology Research Alliance Special Interest Group in Pediatric Skin of Color (PSOCG) convened to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7108d88a33c7a46722ede13bc34fed58
https://doi.org/10.1111/pde.14754
https://doi.org/10.1111/pde.14754
Autor:
Giuseppe Micali, Lawrence A. Schachner, Pearl C Kwong, Lawrence F. Eichenfield, Antonio Torrelo, Gwenolyn B Scott, Mercedes E. Gonzalez, Latanya Benjamin, Thomas Eberlein, Ayman Grada, Anneke Andriessen
Publikováno v:
Journal of Drugs in Dermatology. 19:281-290
Background Impetigo is a common contagious superficial bacterial skin infection. Treatment of localized lesions can be achieved through topical antibiotics. Oral antibiotics are reserved for extensive disease. Increasing antimicrobial resistance to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5966991c50d5b203de8864aba9723c49
https://doi.org/10.36849/jdd.2020.4679
https://doi.org/10.36849/jdd.2020.4679
Publikováno v:
Skin Appendage Disord
Introduction: Giant pilomatrixomas are quite rare and can be clinically challenging to diagnose. Case Presentation: Here, we report a case of a rapidly growing mass on the shoulder of a 12-year-old previously healthy boy. The lesion on his right shou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8184c850b5752fc30e6eec31e82cac7
https://doi.org/10.1159/000507641
https://doi.org/10.1159/000507641